Is GLP-1 similar to Ozempic
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of alzheimers disease
The case for considering it is straightforward: the underlying drug class (GLP-1 receptor agonists) has the strongest weight management evidence base in clinical pharmacology, supported by multiple large-scale randomized controlled trials showing 15-22% weight reduction in study populations over 68-72 weeks
Bone broth is also easy to digest
In this reel, we explain: What was recalled Why it happened Whether patients should be worried Why doctors are asking for greater transparency What you should do if you're taking semaglutide Do not stop your medication without speaking to your treating doctor
Recent registry studies reveal that people taking GLP-1 medications experienced substantially decreased risk of hospitalization due to alcohol use disorder, with semaglutide showing the strongest protection (adjusted hazard ratio 0.64) 25